↓ Skip to main content
What is this page? Embed badge

Combined treatment using adoptive cell therapy, extended pharmacokinetic IL-2, and tumor-specific antibodies leads to cures of established B16F10 tumors and extended in vivo T cell survival

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

patent
2 patents
Summary Patents
So far, Altmetric has seen 2 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.